- Home
- SYTA vs TNFA Comparison
SYTA vs TNFA Comparison
Compare SYTA & TNFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- TNFA
- Stock Information
- Founded
- SYTA N/A
- TNFA 2014
- Country
- SYTA Canada
- TNFA United States
- Employees
- SYTA N/A
- TNFA N/A
- Industry
- SYTA Telecommunications Equipment
- TNFA
- Sector
- SYTA Telecommunications
- TNFA
- Exchange
- SYTA Nasdaq
- TNFA NYSE
- Market Cap
- SYTA 3.3M
- TNFA 3.2M
- IPO Year
- SYTA 2020
- TNFA N/A
- Fundamental
- Price
- SYTA $0.75
- TNFA $1.39
- Analyst Decision
- SYTA
- TNFA
- Analyst Count
- SYTA 0
- TNFA 0
- Target Price
- SYTA N/A
- TNFA N/A
- AVG Volume (30 Days)
- SYTA 2.0M
- TNFA 218.7K
- Earning Date
- SYTA 11-14-2024
- TNFA 11-14-2024
- Dividend Yield
- SYTA N/A
- TNFA N/A
- EPS Growth
- SYTA N/A
- TNFA N/A
- EPS
- SYTA N/A
- TNFA N/A
- Revenue
- SYTA $11,988,979.00
- TNFA N/A
- Revenue This Year
- SYTA $75.92
- TNFA N/A
- Revenue Next Year
- SYTA $19.72
- TNFA N/A
- P/E Ratio
- SYTA N/A
- TNFA N/A
- Revenue Growth
- SYTA 41.59
- TNFA N/A
- 52 Week Low
- SYTA $0.62
- TNFA $1.05
- 52 Week High
- SYTA $90.90
- TNFA $10.68
- Technical
- Relative Strength Index (RSI)
- SYTA 35.57
- TNFA 55.34
- Support Level
- SYTA $0.62
- TNFA $1.05
- Resistance Level
- SYTA $0.94
- TNFA $1.64
- Average True Range (ATR)
- SYTA 0.10
- TNFA 0.15
- MACD
- SYTA 0.00
- TNFA 0.02
- Stochastic Oscillator
- SYTA 15.94
- TNFA 62.71
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About TNFA TNF PHARMACEUTICALS INC EFFEC
TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.